TEVA PHARMACEUTICAL INDUSTRIES LTD Indenture Agreements

14 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Supplemental Senior Indenture for 5.750% Senior Notes due 2030 among Teva Pharmaceutical Finance Netherlands IV B.V., Teva Pharmaceutical Industries Limited, and The Bank of...
Indenture Agreements
TEVA PHARMACEUTICAL INDUSTRIES LTD
Pharmaceuticals
2025
Senior Indenture among Teva Pharmaceutical Finance Netherlands IV B.V., Teva Pharmaceutical Industries Limited, and The Bank of New York Mellon, dated May 28, 2025
Indenture Agreements
TEVA PHARMACEUTICAL INDUSTRIES LTD
Pharmaceuticals
2025
Fifth Supplemental Senior Indenture for 6.000% Senior Notes due 2032 among Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited, and The Bank...
Indenture Agreements
TEVA PHARMACEUTICAL INDUSTRIES LTD
Pharmaceuticals
2025
Fifth Supplemental Senior Indenture for 4.125% Senior Notes due 2031 among Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical Industries Limited, and The Bank of...
Indenture Agreements
TEVA PHARMACEUTICAL INDUSTRIES LTD
Pharmaceuticals
2025
Fourth Supplemental Senior Indenture among Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited, and The Bank of New York Mellon (March 9, 2023)
Indenture Agreements
TEVA PHARMACEUTICAL INDUSTRIES LTD
Pharmaceuticals
NY
2023
Fourth Supplemental Senior Indenture for 7.375% and 7.875% Sustainability-Linked Senior Notes (2029 & 2031) – Teva Pharmaceutical Finance Netherlands II B.V., Teva...
Indenture Agreements
TEVA PHARMACEUTICAL INDUSTRIES LTD
Pharmaceuticals
NY
2023
Third Supplemental Senior Indenture among Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited, and The Bank of New York Mellon (2021)
Indenture Agreements
TEVA PHARMACEUTICAL INDUSTRIES LTD
Pharmaceuticals
NY
2021
Third Supplemental Senior Indenture for 3.750% and 4.375% Sustainability-Linked Senior Notes (2027 & 2030) – Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical...
Indenture Agreements
TEVA PHARMACEUTICAL INDUSTRIES LTD
Pharmaceuticals
NY
2021
Second Supplemental Senior Indenture for 7.125% Senior Notes due 2025 – Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited, and The Bank of...
Indenture Agreements
TEVA PHARMACEUTICAL INDUSTRIES LTD
Pharmaceuticals
NY
2019
Second Supplemental Senior Indenture for 6.000% Senior Notes due 2025 among Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical Industries Limited, and The Bank...
Indenture Agreements
TEVA PHARMACEUTICAL INDUSTRIES LTD
Pharmaceuticals
NY
2019
First Supplemental Senior Indenture for 3.250% Senior Notes due 2022 and 4.500% Senior Notes due 2025 by Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical...
Indenture Agreements
TEVA PHARMACEUTICAL INDUSTRIES LTD
Pharmaceuticals
NY
2018
Senior Indenture among Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical Industries Limited, and The Bank of New York Mellon (March 14, 2018)
Indenture Agreements
TEVA PHARMACEUTICAL INDUSTRIES LTD
Pharmaceuticals
NY
2018
First Supplemental Senior Indenture for 6.000% Senior Notes due 2024 and 6.750% Senior Notes due 2028 (Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical...
Indenture Agreements
TEVA PHARMACEUTICAL INDUSTRIES LTD
Pharmaceuticals
NY
2018
Senior Indenture among Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited, and The Bank of New York Mellon, dated March 14, 2018
Indenture Agreements
TEVA PHARMACEUTICAL INDUSTRIES LTD
Pharmaceuticals
NY
2018